within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01B_AntiarrhythmicsClassIAndIii.C01BA03_Disopyramide;

model Disopyramide
  extends Pharmacolibrary.Drugs.ATC.C.C01BA03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C01BA03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Disopyramide is a class IA antiarrhythmic agent used primarily to treat ventricular arrhythmias, atrial fibrillation, and other severe arrhythmias. It possesses potent sodium channel blocking properties, leads to slowed cardiac conduction, and has negative inotropic and anticholinergic effects. It is approved and in clinical use for cardiac arrhythmia management.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Johnston, A, et al., &amp; Hamer, NA (1980). Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment. <i>British journal of clinical pharmacology</i> 10(3) 245–248. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.1980.tb01751.x\">10.1111/j.1365-2125.1980.tb01751.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7437241/\">https://pubmed.ncbi.nlm.nih.gov/7437241</a></p></li><li><p>Ashford, JJ, et al., &amp; Kidner, PH (1979). Pharmacokinetics of disopyramide administered by intramuscular, intravenous and oral routes to normal volunteers [proceedings]. <i>British journal of pharmacology</i> 66(3) 442P–443P. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/526732/\">https://pubmed.ncbi.nlm.nih.gov/526732</a></p></li><li><p>Lima, JJ, et al., &amp; Leier, CV (1984). Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide. <i>Journal of pharmacokinetics and biopharmaceutics</i> 12(3) 289–313. DOI:<a href=\"https://doi.org/10.1007/BF01061722\">10.1007/BF01061722</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6502472/\">https://pubmed.ncbi.nlm.nih.gov/6502472</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Disopyramide;
